The Efficacy and Safety of TAF vs Other NAs in Patients With LVL

NCT04501224 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis b
Cirrhosis Due to Hepatitis B

Interventions

DRUG: Tenofovir alafenamide fumarate
DRUG: Entecavir or Tenofovir disoproxil fumarate

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University